Home›Stock Screener›Anuh Pharma›Quarterly Results

Anuh Pharma Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹47 Cr
QMarch 2025
Quarterly Results

In 2026, Anuh Pharma (ANUHPHR) reported revenue ₹778 Cr and net profit ₹42 Cr. Compare with Anuh Pharma value estimation to assess whether the stock is under or overvalued.

ANUHPHR Quarterly Results — Revenue, Profit & EPS Highlights

Anuh Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ANUHPHR screener.

  • Revenue of ₹671 Cr in March 2025 (+0.0% vs March 2025, +1.8% vs March 2024)
  • Net Profit of ₹47 Cr in March 2025 (+0.0% vs March 2025, -21.7% vs March 2024)
  • EBITDA of ₹70 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 9.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹9.45 in March 2025 (+0.0% vs March 2025)

Anuh Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ANUHPHR quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 778 671 659 534 492 15.9% -
Net Profit (₹ Cr) 42 47 60 36 31 - -
EBITDA (₹ Cr) 68 70 87 57 52 - -
EPS (₹) 6.20 9.45 11.98 7.22 6.10 - -
Operating Margin (%) 8.0% 9.0% 12.0% 10.0% 10.0% - -

ANUHPHR Share Price Trend — 1-Year Movement Across Quarterly Results

Anuh Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore ANUHPHR price movement history to track price trends across different timeframes.

Profitability Ratios

Profit Margin 7.0%
EBITDA Margin 10.4%
Operating Margin 9.0%
ROE (Annual) 14.4%

Balance Sheet Highlights

Total Assets ₹507 Cr
Total Equity ₹326 Cr
Current Assets ₹376 Cr
Current Liabilities ₹2 Cr

Cash Flow Analysis

Operating Cash Flow ₹37 Cr
Investing Cash Flow ₹-20 Cr
Financing Cash Flow ₹-5 Cr
Net Cash Flow ₹12 Cr

Current Market Data

Current Price ₹78.98
Exchange NSE
Last Updated May 14, 2026

Revenue Trend (₹ Cr)

March 2023 534
March 2024 659
March 2025 671
2026 778

Net Profit Trend (₹ Cr)

March 2023 36
March 2024 60
March 2025 47
2026 42

Operating Margin Trend (%)

March 2023 10.0%
March 2024 12.0%
March 2025 9.0%
2026 8.0%

ANUHPHR vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Anuh Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹443,373.10 Cr 1863.2 14,875 3,125 +10.8% - 21.0% 143.3
Divis Laboratories
Sept 2025 		₹178,235.60 Cr 6921.5 2,860 689 +7.1% - 24.1% 266.5
Torrent Pharmaceuti…
Sept 2025 		₹145,389.39 Cr 4403.9 3,219 591 +11.3% - 18.4% 251.1
Cipla
Mar 2026 		₹107,240.96 Cr 1436.7 6,612 543 -14.3% -4.0% 8.2% 209.1
Dr Reddys Laborator…
Mar 2026 		₹105,607.38 Cr 1303.6 7,996 221 -12.5% -11.5% 2.8% 491.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores